Related Experiment Video
Updated: Aug 8, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
A multidisciplinary overview of cardiogenic shock
1Department of Medicine, Keio University School of Medicine, Tokyo, Japan. minoru_okuda@mqb.biglobe.ne.jp
Shock (Augusta, Ga.)
|May 25, 2006
Summary
Cardiogenic shock after acute myocardial infarction (AMI) involves cardiomyocyte death and energy crisis. Early revascularization and future stem cell therapies offer hope for heart recovery.
Area of Science:
- Cardiology
- Cellular Biology
- Biochemistry
Background:
- Acute myocardial infarction (AMI) can lead to cardiogenic shock, a critical condition.
- The heart's obligate aerobic nature and limited collateral circulation make it vulnerable to ischemic injury.
- Understanding cardiomyocyte adaptive responses and death mechanisms is crucial for managing AMI complications.
Purpose of the Study:
- To review cardiogenic shock complicating AMI from multidisciplinary perspectives.
- To detail the basic and clinical aspects of myocardial energy metabolism and cell death.
- To discuss diagnostic criteria, hemodynamic manifestations, and therapeutic strategies for cardiogenic shock.
Main Methods:
- Review of basic science principles including oxygen diffusion, mitochondrial function, and energy deficits.
- Analysis of cardiomyocyte adaptive responses like the Pasteur Effect and hypoxia-inducible factor (HIF)-1 alpha.
- Discussion of pathological processes including oncosis, autophagy, apoptosis, and reperfusion injury (reactive oxygen species - ROS).
Main Results:
- Simultaneous cardiomyocyte death (billions) occurs following coronary occlusion due to oncosis and/or autophagy.
- Diagnostic criteria (MIRU), hemodynamic profiles, infarct size, and remote myocardial jeopardy define cardiogenic shock.
- Reperfusion injury is a complex factor, and early revascularization (PCI, CABG, IABP) is vital.
Conclusions:
- Cardiogenic shock in AMI results from profound myocardial energy crisis and widespread cardiomyocyte death.
- Early revascularization strategies are critical for improving outcomes in patients with cardiogenic shock.
- Future research directions include promoting collateral channel growth and exploring stem cell therapy for myocardial regeneration.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:30Introduction Cardiac Emergencies
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...